Premature Ovarian Failure
Premature Ovarian Failure - Related Videos
14:26
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
0 Views •
Cited by 16 •
2014
Two exercise paradigms were tested on a newly developed chemically induced menopausal mouse model to examine the impact of menopause on exercise capacity and cardiac adaption to exercise.
04:12
Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
0 Views •
Cited by 3 •
2025
Posthemorrhagic hydrocephalus of prematurity (PHHP) can be modeled in neonatal rats by combining chorioamnionitis and intraventricular hemorrhage. The combination of these prenatal and postnatal events accurately recapitulates the clinical hallmarks of PHHP, including macrocephaly, ventriculomegaly, and elevated intracranial pressure, through the lifespan.
04:35
Obtaining Primary Ovarian Cancer Cells from Solid Specimens: A Method to Culture Epithelial Ovarian Cancer Cells from Ovarian Tumor Specimens
0 Views •
2023
In this video, we describe a method for isolating and characterizing primary ovarian cancer cells from solid ovarian tumor tissue specimens. The epithelial cancer cells obtained using this protocol are suitable for understanding the processes that may lead to ovarian cancer initiation and development.
10:35
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
0 Views •
Cited by 18 •
2010
To study in vivo tumor growth and tumor microenvironment, we used a syngeneic and orthotopic mouse model of ovarian cancer in immunocompetent animals. We transduced a mouse tumor cell line (MOV1) with Katushka fluorescent protein (MOV1KAT) and here we show its orthotopic implantation in ovary and in vivo imaging.
09:25
Transplantation Into the Mouse Ovarian Fat Pad
0 Views •
Cited by 7 •
2016
We describe an ovarian fad pad transplantation assay suitable for studies of normal and transformed epithelia of the female reproductive tract. The mouse fat pad allows transplantation of large tissue fragments, is easily accessible for surgery and imaging, and provides the most favorable native environment for tissues of Müllerian origin.
FAQs
When ovarian estrogen production falls, the normal feedback signal to the hypothalamus and pituitary is reduced. The pituitary consequently produces more follicle-stimulating hormone, while menstrual cycling becomes irregular or may stop. This relationship links ovarian activity with central endocrine regulation, making hormone patterns important for understanding how impaired follicle function affects the reproductive system.
Studying premature ovarian failure gives biologists a model for examining why ovarian follicles become depleted or function abnormally earlier than expected. Comparing these mechanisms with normal reproductive development can help clarify the biological processes associated with ovarian aging, while also highlighting that ovarian function depends on both follicle status and hormonal signaling.
Research considers genetic and autoimmune influences because either may be associated with abnormal ovarian function or earlier follicle loss. Examining these influences places the condition within broader studies of reproductive biology rather than treating it as only a menstrual disorder. It can also help explain why ovarian impairment develops through different biological pathways.
Clinical evaluation helps characterize disrupted ovarian function and its consequences rather than relying on menstrual changes alone. In reproductive medicine, the findings support fertility counseling, symptom management, and discussion of long-term risks linked with reduced estrogen exposure. Its value is therefore both immediate, for care planning, and interpretive, for understanding the hormonal effects.
Fertility counseling addresses the connection between impaired ovarian function and reduced fertility. Counseling can help patients understand the reproductive implications of altered follicle activity and consider management within the context of their individual evaluation. This application translates biological findings into reproductive planning, while recognizing that the condition also has hormonal effects beyond fertility alone.
Management must consider symptoms associated with reduced estrogen as well as longer-term risks of reduced estrogen exposure. This broader focus reflects the fact that ovarian hormones have effects beyond menstrual regularity or fertility. In practice, reproductive medicine uses evaluation to connect symptom care, fertility discussions, and attention to health risks related to altered ovarian hormone production.